Article
A trimethoprim derivative impedes antibiotic resistance evolution.
Nature communications - 19 May 2021
Manna Madhu Sudan, Tamer Yusuf Talha, Gaszek Ilona, Poulides Nicole, Ahmed Ayesha, Wang Xiaoyu, Toprak Furkan C R, Woodard DaNae R, Koh Andrew Y, Williams Noelle S, Borek Dominika, Atilgan Ali Rana, Hulleman John D, Atilgan Canan, Tambar Uttam, Toprak Erdal
Abstract excerpt
The antibiotic trimethoprim (TMP) is used to treat a variety of Escherichia coli infections, but its efficacy is limited by the rapid emergence of TMP-resistant bacteria. Previous laboratory evolution experiments have identified resistance-conferring mutations in the gene encoding the TMP target, bacterial dihydrofolate reductase (DHFR), in particular mutation L28R. Here, we show that 4'-desmethyltrimethoprim...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
